SCHEMBL23229196

SCHEMBL23229196

CCc1cccc(-c2cc(C(F)F)c3occ(COc4ccccc4CC(=O)O)c3c2)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CFD P00746 19/20 0.50
F11 P03951 12/20 0.50
TPSB2 P20231 9/20 0.50
KLKB1 P03952 4/20 0.50
PLG P00747 2/20 0.50
PLAU P00749 2/20 0.50
F7 P08709 2/20 0.50
PTGER1 P34995 1/20 0.42
PTGER4 P35408 1/20 0.42
PTGER3 P43115 1/20 0.42
PTGER2 P43116 1/20 0.42
F2 P00734 1/20 0.40
F9 P00740 1/20 0.40
F10 P00742 1/20 0.40
PLAT P00750 1/20 0.40
PTGS1 P23219 1/20 0.40
SLC18A2 Q05940 1/20 0.40
PDE4D Q08499 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23219187 0.92 CFD (0.62) CFDF11TPSB2KLKB1PLG
SCHEMBL29852721 0.92 CFD (0.62) CFDF11TPSB2KLKB1PLG
SCHEMBL23229195 0.91 CFD (0.42) CFDF11TPSB2KLKB1PLG
SCHEMBL23218961 0.85 CFD (0.49) CFDF11TPSB2KLKB1PLG
SCHEMBL29852853 0.85 CFD (0.49) CFDF11TPSB2KLKB1PLG
SCHEMBL29853183 0.82 CFD (0.58) CFDF11TPSB2KLKB1PLG
SCHEMBL23218593 0.82 CFD (0.58) CFDF11TPSB2KLKB1PLG
SCHEMBL23229126 0.82 CFD (0.55) CFDF11TPSB2KLKB1PLG
SCHEMBL28736236 0.81 CFD (0.44) CFDF11TPSB2KLKB1PLG
SCHEMBL23218742 0.80 CFD (0.65) CFDF11TPSB2KLKB1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed